Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?

S L Berga1, T L Daniels

  • 1Department of Obstetrics, University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pennsylvania 15213-3180, USA.

Seminars in Reproductive Endocrinology
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys.

Neuroscience·2013
Same author

Neuropsychological functioning in girls with premature adrenarche.

Journal of the International Neuropsychological Society : JINS·2011
Same author

Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet.

Human reproduction (Oxford, England)·2010
Same author

Metabolic and reproductive consequences of the serotonin transporter promoter polymorphism (5-HTTLPR) in adult female rhesus monkeys (Macaca mulatta).

Endocrine·2007
Same author

Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity.

Nature neuroscience·2006
Same author

The diagnosis and treatment of stress-induced anovulation.

Minerva ginecologica·2005
Same journal

Endocrine cancer risks for women during the perimenopause and beyond.

Seminars in reproductive endocrinology·2000
Same journal

Aromatase in aging women.

Seminars in reproductive endocrinology·2000
Same journal

Reproductive hormones, aging, and sleep.

Seminars in reproductive endocrinology·2000
Same journal

Changes in adrenocortical function with aging and therapeutic implications.

Seminars in reproductive endocrinology·2000
Same journal

Age-related changes in growth hormone secretion: should the somatopause be treated?

Seminars in reproductive endocrinology·2000
Same journal

Menstrual bleeding, hormones, and the menopausal transition.

Seminars in reproductive endocrinology·2000
See all related articles

Polycystic ovary syndrome (PCOS) involves characteristic ovarian changes driven by altered hypothalamic-pituitary secretion, specifically luteinizing hormone (LH) excess and follicle-stimulating hormone (FSH) deficiency. Understanding this link is crucial for developing effective PCOS treatments.

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Pathophysiology

Background:

  • Polycystic ovary syndrome (PCOS) is a complex endocrine disorder.
  • Ovarian morphology in PCOS is characterized by thecal and stromal hyperplasia.
  • This morphology is linked to specific hormonal imbalances.

Purpose of the Study:

  • To explore the relationship between hypothalamic-pituitary secretion alterations and polycystic ovarian (PCO) morphology.
  • To elucidate the roles of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in PCOS development.
  • To identify potential treatment implications arising from these hormonal dependencies.

Main Methods:

  • The study focuses on the pathogenetic pathways leading to PCO morphology.
  • It analyzes the interplay between gonadotropin secretion and ovarian changes.

Related Experiment Videos

  • The research is primarily theoretical, based on existing physiological understanding.

    • Main Results:

    • PCO morphology requires both LH excess and FSH deficiency for its development and maintenance.
    • Altered hypothalamic-pituitary secretion is integral to expressing PCO morphology.
    • These hormonal changes are necessary but not necessarily the primary cause of PCOS.

    Conclusions:

    • The development of PCO morphology is dependent on specific alterations in LH and FSH secretion.
    • While not the primary etiology, these gonadotropin changes are critical for PCOS manifestation.
    • Recognizing the link between gonadotropin alterations and PCO state has significant treatment implications for PCOS management.